Novartis

Why Legend Biotech Stock Is Having Its Best Month Yet

Notable Insider Buys: Novartis, T-Mobile And More

Barron's On: Pharma's Big Hope

Notable Insider Buys: Novartis, T-Mobile And More

Barron's On: Pharma's Big Hope

9 Notable Biotechs Presenting At This Year's ASH Meeting (Dec. 9-12)

Barron's Picks And Pans: Amazon, Novartis, Tesla And More

9 Notable Biotechs Presenting At This Year's ASH Meeting (Dec. 9-12)

Barron's Picks And Pans: Amazon, Novartis, Tesla And More

Cowen Downgrades Novartis, Strengths 'Now Balance Its Risks'

Short Interest In Conatus Pharmaceuticals Surges

Novartis Recent News

Barron's Best Income Ideas For 2017

Barron's Picks And Pans: Trump Stocks, Hillary Stocks, Safe European Yields And More

Regeneron Is 'One Of The Stronger Growers In Biotech'

Novartis' CEO Says Company Open To Selling Its $14 Billion Stake In Roche 'If The Opportunity Were Right'

Novartis Announces The Establishment Of FortiHFy, But What Is It?

Bayer's Latest Stage 2 Trial Could Be A Boon For Shares

Repeat Performance In Aveo Pharmaceuticals After Spike In Price

Markets Continue To Rally As The Dow Closes Above 17,000

5 New Medical Technologies For Diabetics

Novartis Joins Google To Develop Contacts For Diabetics

Markets Sell-Off After Malaysian Airline Crash In Ukraine

Markets Mixed, NASDAQ Lower As Yellen Suggests Valuations Are Stretched

ASCO Meeting Day 1: Preserving Fertility And Reducing Side Effects

Surges In Biotech Short Interest (INCY, PCYC, REGN)

Market Wrap For April 24: Apple's Smashing Earnings Overshadowed By Ukraine Concerns

Market Wrap For April 22: S&P Rises For Sixth Straight Day, Dow & Nasdaq Also Positive

Market Wrap For March 27: Markets Lower Following Mixed Economic Data

Market Wrap For March 25: Markets Snap Two-Day Losing Steak On Confidence Data

Market Wrap For March 18: Markets Positive Despite Crimea Concerns

Market Wrap For March 7: Markets Cap Off Positive Week With Small Gains

The Top Five Dow Stocks In February

Market Wrap For February 26: Markets Slightly Higher On Housing Data

GlaxoSmithKline, Kinder Morgan And Others Insiders Have Been Buying